Skip to Content

Curaleaf Holdings Inc CURLF

Morningstar Rating
$5.00 +0.25 (5.26%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Curaleaf's Medium-Term Growth Should Benefit From Its European Investments and US Market Expansions

Curaleaf cultivates and sells cannabis in the US with a presence in 17 states. Vertically integrated, Curaleaf produces through 21 cultivation sites and sells directly through 147 dispensaries and wholesale to other dispensaries. Compared with other multistate operators, Curaleaf has generally employed a more aggressive growth strategy, which hasn't always paid off, leading to exits and sales.

Price vs Fair Value

CURLF is trading at a 63% discount.
Price
$4.82
Fair Value
$94.00
Uncertainty
Very High
1-Star Price
$65.81
5-Star Price
$4.20
Economic Moat
Pcsb
Capital Allocation
Qyyxmbl

Bulls Say, Bears Say

Bulls

Unique among US multistate operators, Curaleaf's acquisitions into Europe and Canada allow it to serve the growing European market as legalization expands.

Bears

Sales growth for legal sellers like Curaleaf are challenged by the lack of taxes in the illicit market.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CURLF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$4.75
Day Range
$4.745.26
52-Week Range
$2.295.91
Bid/Ask
$4.90 / $5.01
Market Cap
$3.68 Bil
Volume/Avg
532,929 / 899,820

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.69
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
5,650

Competitors

Valuation

Metric
CURLF
TLRY
GTII
Price/Earnings (Normalized)
42.17
Price/Book Value
3.490.411.69
Price/Sales
2.691.712.70
Price/Cash Flow
63.4110.99
Price/Earnings
CURLF
TLRY
GTII

Financial Strength

Metric
CURLF
TLRY
GTII
Quick Ratio
0.310.961.62
Current Ratio
0.851.922.72
Interest Coverage
−0.24−4.398.83
Quick Ratio
CURLF
TLRY
GTII

Profitability

Metric
CURLF
TLRY
GTII
Return on Assets (Normalized)
−3.72%−13.42%3.06%
Return on Equity (Normalized)
−10.45%−17.13%4.55%
Return on Invested Capital (Normalized)
−2.20%−14.23%3.80%
Return on Assets
CURLF
TLRY
GTII
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AXbqhmxvfxfPbc$72.4 Bil
MKKGY
Merck KGaA ADRHyyrfbrgWwrzzr$70.8 Bil
HLN
Haleon PLC ADRBkdfkrkgJtbk$38.2 Bil
VTRS
Viatris IncZjzlcbsQfvkd$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRNwhgshhnzMglw$12.5 Bil
CTLT
Catalent IncZtsqtxrlgTjfmwd$10.1 Bil
PRGO
Perrigo Co PLCKrwrfcytCdmy$4.3 Bil
PBH
Prestige Consumer Healthcare IncLspfjbxQwsgwh$3.5 Bil
GTBIF
Green Thumb Industries IncTvjsyhbzvJxmqk$2.9 Bil

Sponsor Center